Preclinical evaluation of vascular closure devices

Area of Science:

• Cardiovascular Devices
• Medical Device Preclinical Evaluation
• Interventional Cardiology

Background:

• Vascular closure devices (VCDs) are crucial for achieving hemostasis after femoral artery access during interventional procedures.
• Current preclinical evaluation of VCDs lacks standardized methodologies, despite their widespread use and ongoing technological advancements.
• Existing literature on VCD preclinical assessment is limited, creating a gap in understanding device-specific nuances.

Purpose of the Study:

• To address the paucity of literature on preclinical evaluation of VCDs.
• To discuss conventional animal models used for VCD assessment.
• To highlight attributes, limitations, and standards for in vivo evaluation of VCD performance and safety.

Main Methods:

• Review of existing literature on VCDs and animal models for preclinical testing.
• Discussion of device-specific considerations in VCD evaluation.
• Analysis of standards for assessing in vivo performance, handling, and safety.

Main Results:

• Preclinical evaluation of VCDs requires careful consideration of device-specific factors and animal model selection.
• Standardized approaches are needed for consistent and reliable assessment of VCDs in vivo.
• Animal models offer valuable insights into VCD performance and safety but have inherent limitations.

Conclusions:

• A standardized framework for preclinical VCD evaluation using appropriate animal models is essential.
• Further research and consensus are needed to establish robust standards for VCD in vivo testing.
• Improved preclinical assessment will enhance the safety and efficacy of VCDs in clinical practice.